Sparing effect by montelukast treatment for chronic graft versus host disease: A pilot study

Transplantation

Volumn 83, Issue 5, 2007, Pages 577-581

  Or, Reuven ^a   Gesundheit, Benjamin ^a   Resnick, Igor ^a   Bitan, Menachem ^a   Avraham, Amar ^a   Avgil, Meytal ^a   Sacks, Zadok ^a   Shapira, Michael Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone marrow transplantation; Eosinophils; Graft versus host disease; Montelukast; Singulair

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THALIDOMIDE;

ADOLESCENT; ADULT; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EOSINOPHIL; FEMALE; GASTROINTESTINAL TRACT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER; MALE; MORBIDITY; MORTALITY; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELAPSE; SKIN; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ACETATES; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PILOT PROJECTS; QUINOLINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33947320757     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000255575.03795.df     Document Type: Article

References (30)

1. Jaksch M, Mattsson J. The pathophysiology of acute graft-versus-host disease. Scand J Immunol 2005; 61: 398.
2. Cooke KR, Yanik G. Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 2004; 34: 753.
3. Horvathova M. Human eosinophils as potent inflammatory cells and their apoptosis. Bratisl Lek Listy 2004; 105: 359.
4. Daneshpouy M, Socie G, Lemann M, et al. Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood 2002; 99: 3033.
5. Hui Y, Funk CD. Cysteinyl leukotriene receptors. Biochem Pharmacol 2002; 64: 1549.
6. Spada CS, Nieves AL, Krauss AH, Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994; 55: 183.
7. Joris I, Majno G, Corey EJ, Lewis RA. The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction. Am J Pathol 1987; 126: 19.
8. Dahlen SE, Bjork J, Hedqvist P, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A 1981; 78: 3887.
9. Tohda Y, Nakahara H, Kubo H, et al. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 1999; 29: 1532.
10. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163: 226.
11. Bautz F, Denzlinger C, Kanz L, Mohle R. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood 2001; 97: 3433.
12. Machida I, Matsuse H, Kondo Y, et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 2004; 172: 1833.
13. Howarth PH. Leukotrienes in rhinitis. Am J Respir Crit Care Med 2000; 161: S133.
14. Pullerits T, Praks L, Skoogh BE, et al. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 1999; 159: 1814.
15. Rackal JM, Vender RB. The treatment of atopic dermatitis and other dermatoses with leukotriene antagonists. Skin Therapy Lett 2004; 9: 1.
16. Neustrom MR, Friesen C. Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol 1999; 104: 506.
17. Schmitt-Grohe S, Eickmeier O, Schubert R, et al. Anti-inflammatory effects of montelukast in mild cystic fibrosis. Ann Allergy Asthma Immunol 2002; 89: 599.
18. Okunishi K, Dohi M, Nakagome K, et al. A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol 2004; 173: 6393.
19. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945.
20. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295.
21. Martin PJ, Weisdorf D, Przepiorka D, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491.
22. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 1998; 279: 1181.
23. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001; 108: E48.
24. Iwasaki T. Recent advances in the treatment of graft-versus-host disease. Clin Med Res 2004; 2: 243.
25. Basara N, Kiehl MG, Fauser AA. Eosinophilia indicates the evolution to acute graft-versus-host disease. Blood 2002; 100: 3055.
26. Stelmach I, Gorski P, Jerzynska J, et al. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children. Ann Allergy Asthma Immunol 2002; 89: 67.
27. Braccioni F, Dorman SC, O'Byrne PM, et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 2002; 110: 96.
28. Mao H, Yin KS, Wang ZL, et al. Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice. Chin Med J (Engl) 2004; 117: 592.
29. Gelfand EW, Dakhama A. CD8+ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma. J Allergy Clin Immunol 2006; 117: 577.
30. Langlois A, Ferland C, Tremblay GM, Laviolette M. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism. J Allergy Clin Immunol 2006; 118: 113.